A former U.S. Marine from Shelburne Falls pleaded guilty to making false statements regarding injuries he received in the line of duty and was overpaid $344,040 in disability benefits by the VA.

The U.S. Department of Justice shared the providers agreed to pay to resolve alleged violations arising from their involvement in laboratory kickback schemes.

President Donald Trump put the brakes on billions in federal funding. Here’s how it’s affecting research and development ...

Alterome Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the development of next-generation, small molecule targeted therapies for the treatment of cancer, today announced ...

Dissolving Clusters of Cancer Cells to Prevent Metastases Jan. 24, 2025 — Successful test in breast cancer patients: the active agent digoxin ... Monitoring for Ductal Carcinoma in Situ Dec ...

The authors convincingly showed that enhanced TRPV4 plasmamembrane localization correlates with highgrade DCIS cells in patient tissue samples ... at low confluence with PEG 3000 (a hyperosmotic agent ...

and Special Agent in Charge Jason Sargenski of the Department of Defense Office of Inspector General, Defense Criminal Investigative Service (DCIS), Southeast Field Office made the announcement.

It offers Hylenex recombinant, a formulation of rHuPH20 that facilitates subcutaneous (SC) administration to enhance the dispersion and absorption of other injected drugs in SC urography and to ...